miR-646 and miR-381-3p reversed CASC11-mediated phenotypes of CRC progression and restored the regulatory effects of CASC11 on RAB11FIP2 and the phosphorylation levels of the PI3K/AKT pathway. The gene discussed is AKT1; the disease is colorectal carcinoma.